A Luxen

Author PubWeight™ 73.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Baseline brain activity fluctuations predict somatosensory perception in humans. Proc Natl Acad Sci U S A 2007 2.78
2 Functional neuroanatomy of human rapid-eye-movement sleep and dreaming. Nature 1996 2.40
3 Impaired effective cortical connectivity in vegetative state: preliminary investigation using PET. Neuroimage 1999 2.39
4 Hemodynamic cerebral correlates of sleep spindles during human non-rapid eye movement sleep. Proc Natl Acad Sci U S A 2007 2.34
5 Experience-dependent changes in cerebral activation during human REM sleep. Nat Neurosci 2000 2.18
6 Functional connectivity in the default network during resting state is preserved in a vegetative but not in a brain dead patient. Hum Brain Mapp 2009 1.72
7 Cortical processing of noxious somatosensory stimuli in the persistent vegetative state. Neuroimage 2002 1.71
8 Restoration of thalamocortical connectivity after recovery from persistent vegetative state. Lancet 2000 1.59
9 High-yield radiosynthesis and preliminary in vivo evaluation of p-[18F]MPPF, a fluoro analog of WAY-100635. Nucl Med Biol 1998 1.54
10 Biochemical and autoradiographic measurements of brain serotonin synthesis rate in the freely moving rat: a reexamination of the alpha-methyl-L-tryptophan method. J Neurochem 1999 1.52
11 Multicompartmental study of fluorine-18 altanserin binding to brain 5HT2 receptors in humans using positron emission tomography. Eur J Nucl Med 1994 1.42
12 Frontal and parietal metabolic disturbances in unipolar depression. Biol Psychiatry 1994 1.40
13 Neural mechanisms of antinociceptive effects of hypnosis. Anesthesiology 2000 1.32
14 Functional neuroanatomy of human slow wave sleep. J Neurosci 1997 1.32
15 Striatum forever, despite sequence learning variability: a random effect analysis of PET data. Hum Brain Mapp 2000 1.29
16 Regional brain activity during working memory tasks. Brain 1996 1.29
17 Auditory processing in the vegetative state. Brain 2000 1.28
18 Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. J Nucl Med 1998 1.25
19 Spectral quality of light modulates emotional brain responses in humans. Proc Natl Acad Sci U S A 2010 1.16
20 Brain activation induced by estimation of duration: a PET study. Neuroimage 1996 1.08
21 Direct comparison of [13N]ammonia and [15O]water estimates of perfusion with quantification of regional myocardial blood flow by microspheres. Circulation 1993 1.02
22 Noninvasive quantitation of regional myocardial oxygen consumption in vivo with [1-11C]acetate and dynamic positron emission tomography. Circulation 1989 1.00
23 Functional neuroanatomy of hypnotic state. Biol Psychiatry 1999 0.99
24 Carbon-11-methionine and fluorine-18-FDG PET study in brain hematoma. J Nucl Med 1994 0.96
25 Experience-dependent changes in cerebral functional connectivity during human rapid eye movement sleep. Neuroscience 2001 0.95
26 Computer-controlled radiochemical synthesis: a chemistry process control unit for the automated production of radiochemicals. Int J Rad Appl Instrum A 1989 0.94
27 Pain and non-pain processing during hypnosis: a thulium-YAG event-related fMRI study. Neuroimage 2009 0.93
28 Fluorine-18-fluorodeoxyglucose positron emission tomography for preoperative parathyroid imaging in primary hyperparathyroidism. Eur J Nucl Med 1995 0.93
29 The functional anatomy of inhibition processes investigated with the Hayling task. Neuroimage 2001 0.92
30 Generation of rapid eye movements during paradoxical sleep in humans. Neuroimage 2001 0.92
31 Hypnotic modulation of resting state fMRI default mode and extrinsic network connectivity. Prog Brain Res 2011 0.92
32 Reversible striatal hypermetabolism in a case of Sydenham's chorea. Mov Disord 1993 0.91
33 Neural and cognitive bases of upper limb apraxia in corticobasal degeneration. Neurology 2001 0.90
34 Brain hypometabolism of glucose in anorexia nervosa: a PET scan study. Biol Psychiatry 1995 0.90
35 Brain hypometabolism of glucose in anorexia nervosa: normalization after weight gain. Biol Psychiatry 1996 0.90
36 Hemibody tremor related to stroke. Stroke 1993 0.89
37 Epimerization study on [18f]FDG produced by an alkaline hydrolysis on solid support under stringent conditions. Appl Radiat Isot 2002 0.88
38 Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose. J Neurosurg 1995 0.88
39 PET scanning and neuronal loss in acute vegetative state. Lancet 2000 0.86
40 PET radiopharmaceuticals in Europe: current use and data relevant for the formulation of summaries of product characteristics (SPCs). Eur J Nucl Med 1995 0.85
41 The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography. J Nucl Med 1992 0.84
42 Basal ganglia and frontal lobe glucose metabolism. A reproducibility positron emission tomography study. J Neuroimaging 1995 0.84
43 Revelations from the unconscious: studying residual brain function in coma and related states. Bull Mem Acad R Med Belg 2008 0.84
44 Positron emission tomography and histopathology in Creutzfeldt-Jakob disease. Neurology 1993 0.82
45 Brain glucose metabolism and dopamine D2 receptor analysis in a patient with hemiparkinsonism-hemiatrophy syndrome. Mov Disord 1993 0.81
46 Tissue distribution, autoradiography, and metabolism of 4-(2'-methoxyphenyl)-1-[2' -[N-2"-pyridinyl)-p-[(18)F]fluorobenzamido]ethyl]piperazine (p-[(18)F]MPPF), a new serotonin 5-HT(1A) antagonist for positron emission tomography: An In vivo study in rats. J Neurochem 2000 0.81
47 The effects of carbidopa on the metabolism of 6-[18F]fluoro-L-dopa in rats, monkeys and humans. Life Sci 1990 0.80
48 Altered frontostriatal relationship in unmedicated schizophrenic patients. Psychiatry Res 1995 0.79
49 The role of lateral occipitotemporal junction and area MT/V5 in the visual analysis of upper-limb postures. Neuroimage 2000 0.79
50 Acute effect of carmustine on glucose metabolism in brain and glioblastoma. Cancer 1994 0.79
51 The neural correlates of updating information in verbal working memory. Memory 2000 0.79
52 A PET investigation of lexicality and phonotactic frequency in oral language processing. Cogn Neuropsychol 2002 0.79
53 Characterization of 4-(2-hydroxyphenyl)-1-[2'-[N-(2''-pyridinyl)-p-fluorobenzamido]ethyl]piperazine (p-DMPPF) as a new potent 5-HT1A antagonist. Br J Pharmacol 2007 0.78
54 Effects of incidental and intentional feature binding on recognition: a behavioural and PET activation study. Neuropsychologia 2002 0.78
55 Comparative in vivo metabolism of 6-[18F]fluoro-L-dopa and [3H]L-dopa in rats. Biochem Pharmacol 1990 0.78
56 Effect of catechol-O-methyl transferase inhibition on peripheral and central metabolism of 6-[18F]fluoro-L-dopa. Eur J Pharmacol 1994 0.78
57 [Cerebral functions in brain-damaged patients. What is meant by coma, vegetative state, minimally conscious state, locked-in syndrome and brain death?]. Anaesthesist 2004 0.77
58 Biological carrier molecules of radiopharmaceuticals for molecular cancer imaging and targeted cancer therapy. Curr Pharm Des 2014 0.77
59 In vivo binding of [18F]altanserin to rat brain 5HT2 receptors: a film and electronic autoradiographic study. Nucl Med Biol 1997 0.77
60 Temporal glucose metabolism in borderline personality disorder. Psychiatry Res 1994 0.77
61 [Contribution of functional neuroimaging studies to the understanding of the mechanisms of general anesthesia]. Rev Med Liege 2009 0.77
62 Hybrid microPET imaging for dosimetric applications in mice: improvement of activity quantification in dynamic microPET imaging for accelerated dosimetry applied to 6-[18 F]fluoro-L-DOPA and 2-[18 F]fluoro-L-tyrosine. Mol Imaging Biol 2014 0.77
63 Bispectral index correlates with regional cerebral blood flow during sleep in distinct cortical and subcortical structures in humans. Arch Ital Biol 2009 0.77
64 [(18)F]p-MPPF: aA radiolabeled antagonist for the study of 5-HT(1A) receptors with PET. Nucl Med Biol 2000 0.76
65 [Functional neuroimaging (fMRI, PET and MEG): what do we measure?]. Rev Med Liege 2008 0.76
66 Contribution of lexico-semantic processes to verbal short-term memory tasks: a PET activation study. Memory 2001 0.76
67 Changes in metabolism of cerebral glucose after stereotactic leukotomy for refractory obsessive-compulsive disorder: a case report. J Neurol Neurosurg Psychiatry 1995 0.76
68 Metabolic correlates of clinical heterogeneity in questionable Alzheimer's disease. Neurobiol Aging 2007 0.76
69 Use of positron emission tomography (PET) in stereotactic conditions for brain biopsy. Acta Neurochir (Wien) 1995 0.75
70 No-carrier-added 3-(2'-[18F]fluoroethyl)spiperone, a new dopamine receptor-binding tracer for positron emission tomography. Int J Rad Appl Instrum B 1986 0.75
71 Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study. Mol Imaging Biol 2015 0.75
72 Synthesis of 4-[18F]fluoro-L-m-tyrosine: a model analog for the in vivo assessment of central dopaminergic function. Int J Rad Appl Instrum A 1990 0.75
73 L-amino acid load to enhance PET differentiation between tumor and inflammation: an in vitro study on (18)F-FET uptake. Contrast Media Mol Imaging 2006 0.75
74 Positron emission tomography-guided stereotactic brain biopsy. Neurosurgery 1992 0.75
75 Interregional correlation of cerebral glucose metabolism in unmedicated schizophrenia. Eur Neuropsychopharmacol 1996 0.75
76 4-[18F]fluoro-L-m-tyrosine: an L-3,4-dihydroxyphenylalanine analog for probing presynaptic dopaminergic function with positron emission tomography. J Neurochem 1989 0.75
77 Production, automatic delivery and bolus injection of [15O]water for positron emission tomography studies. Nucl Med Biol 1996 0.75
78 Effect of pergolide on endogenous and exogenous L-DOPA metabolism in the rat striatum: a microdialysis study. J Neural Transm Gen Sect 1995 0.75
79 [No hypofrontality in schizophrenia demonstrated by positron emission tomography]. Acta Psychiatr Belg 1994 0.75
80 [Decrease in the frontal-superobasal metabolic ratio in unipolar depression]. Acta Psychiatr Belg 1996 0.75
81 [Behavioural assessment and functional neuro-imaing in vegetative state patients]. Rev Med Liege 2007 0.75
82 Stereospecific approach to the synthesis of [18F]2-deoxy-2-fluoro-D-mannose. Int J Rad Appl Instrum A 1986 0.75
83 [Cerebral lesions following convulsive partial status epilepticus. Clinical, neuroradiologic and PET study of a case]. J Neuroradiol 1994 0.75